At close: 3:29:56 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
11,732,460.00
10,769,590.00
9,253,980.00
7,997,740.00
4,095,640.00
Cost of Revenue
7,986,620.00
7,505,120.00
7,010,830.00
6,263,950.00
3,143,090.00
Gross Profit
3,745,840.00
3,264,470.00
2,243,150.00
1,733,790.00
952,550.00
Operating Expense
2,151,480.00
1,849,170.00
1,191,570.00
846,930.00
461,200.00
Operating Income
1,594,360.00
1,415,300.00
1,051,580.00
886,860.00
491,350.00
Net Non Operating Interest Income Expense
-41,760.00
-177,280.00
-192,620.00
-55,390.00
-36,920.00
Pretax Income
1,608,630.00
1,295,290.00
917,950.00
857,200.00
463,440.00
Tax Provision
425,350.00
351,840.00
238,410.00
217,670.00
118,440.00
Net Income Common Stockholders
1,183,280.00
943,450.00
679,540.00
639,530.00
345,000.00
Diluted NI Available to Com Stockholders
1,183,280.00
943,450.00
679,540.00
639,530.00
345,000.00
Basic EPS
22.85
18.66
11.87
11.18
6.03
Diluted EPS
22.85
18.66
11.87
11.18
6.03
Basic Average Shares
57,224.93
50,563.90
57,224.93
57,224.93
57,224.93
Diluted Average Shares
57,224.93
50,563.90
57,224.93
57,224.93
57,224.93
Rent Expense Supplemental
--
3,630.00
1,140.00
810.00
870.00
Total Expenses
10,138,100.00
9,354,290.00
8,202,400.00
7,110,880.00
3,604,290.00
Net Income from Continuing & Discontinued Operation
1,183,280.00
943,450.00
679,540.00
639,530.00
345,000.00
Normalized Income
1,196,542.55
956,582.51
666,022.49
640,470.09
345,312.65
Interest Income
--
37,280.00
7,110.00
1,410.00
2,350.00
Interest Expense
76,450.00
211,970.00
189,360.00
53,020.00
35,860.00
Net Interest Income
-41,760.00
-177,280.00
-192,620.00
-55,390.00
-36,920.00
EBIT
1,685,080.00
1,507,260.00
1,107,310.00
910,220.00
499,300.00
EBITDA
1,866,910.00
1,666,830.00
1,218,080.00
985,250.00
555,160.00
Reconciled Cost of Revenue
7,986,620.00
7,505,120.00
7,010,830.00
6,263,950.00
3,143,090.00
Reconciled Depreciation
181,830.00
159,570.00
110,770.00
75,030.00
55,860.00
Net Income from Continuing Operation Net Minority Interest
1,183,280.00
943,450.00
679,540.00
639,530.00
345,000.00
Total Unusual Items Excluding Goodwill
-18,030.00
-18,030.00
18,260.00
-1,260.00
-420.00
Total Unusual Items
-18,030.00
-18,030.00
18,260.00
-1,260.00
-420.00
Normalized EBITDA
1,884,940.00
1,684,860.00
1,199,820.00
986,510.00
555,580.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-4,767.45
-4,897.49
4,742.49
-319.91
-107.35
3/31/2021 - 12/29/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
JAGSNPHARM.NS Jagsonpal Pharmaceuticals Limited
662.90
-2.28%
ALBERTDAVD.NS Albert David Limited
1,440.80
-2.94%
KILITCH.NS Kilitch Drugs (India) Limited
323.20
-1.67%
HESTERBIO.NS Hester Biosciences Limited
2,388.85
-1.74%
VENUSREM.NS Venus Remedies Limited
340.45
+0.65%
UNICHEMLAB.NS Unichem Laboratories Limited
763.20
-1.62%
BROOKS.NS Brooks Laboratories Limited
147.90
+2.00%
INDOCO.NS Indoco Remedies Limited
335.15
-1.90%
FDC.NS FDC Limited
510.15
-1.88%
APLLTD.NS Alembic Pharmaceuticals Limited
1,046.00
-4.21%